Actively Recruiting
Utilizing the Michigan Neuropathy Screening Instrument for Early Detection of Diabetic Neuropathy
Led by Sohag University · Updated on 2024-07-30
100
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study aims to Compare the diagnostic accuracy of the Michigan Neuropathy Screening Instrument (MNSI) (using MNS questionnaire, ,Inspection, vibratory sensation, Ankle reflexes Exam, 10 g monofilament needle examination), routine NCS, and the U/S of the median, posterior tibial, and sural nerves in identifying diabetic peripheral neuropathy in patients recently diagnosed with type 2 diabetes.
CONDITIONS
Official Title
Utilizing the Michigan Neuropathy Screening Instrument for Early Detection of Diabetic Neuropathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 30 and 55 years
- Diagnosed with type 2 diabetes
- Diabetes diagnosis within 1 year according to World Health Organization 1999 criteria
You will not qualify if you...
- Known hereditary sensory neuropathy
- Vitamin B12 or folate deficiency
- Paraneoplastic conditions
- Autoimmune diseases
- Uremia
- Hypothyroidism
- Ethanol abuse
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Faculty of medecine Sohag university
Sohag, Egypt
Actively Recruiting
Research Team
R
Reda Khalaf Allah Khalil, Resident
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here